SEC filings and other documents

Explore the latest company documents and SEC filings from the company, including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

2026

Earnings, Q2 FY2026

Aug 14, 2026

Q2 2026 marked rebranding, clinical progress, and higher losses amid commercial expansion.

Investor update

Jun 30, 2026

Earnings, Q1 FY2026

May 15, 2026

AGM 2026

May 14, 2026

2026 AANS Annual Scientific Meeting presentation

May 8, 2026

Business update

Jan 22, 2026

2025

Earnings, Q4 FY2025

Mar 12, 2026

Earnings, Q3 FY2025

Oct 30, 2025

Earnings, Q2 FY2025

Aug 14, 2025

Business Update

Jun 26, 2025

Earnings, Q1 FY2025

May 30, 2025

2024

Earnings, Q4 FY2024

Mar 27, 2025

Earnings, Q3 FY2024

Nov 14, 2024

H.C. Wainwright 26th Annual Global Investment Conference 2024

Sep 9, 2024

Earnings, Q2 FY2024

Aug 14, 2024

Earnings, Q1 FY2024

May 15, 2024

Study Update

May 9, 2024

2023

Earnings, Q4 FY2023

Mar 5, 2024

Earnings, Q3 FY2023

Oct 31, 2023

Earnings, Q2 FY2023

Aug 14, 2023

Canaccord Genuity 43rd Annual Growth Conference

Aug 9, 2023

Earnings, Q1 FY2023

Apr 20, 2023

2022

Earnings, Q4 FY2022

Feb 23, 2023

Earnings, Q3 FY2022

Oct 20, 2022

Cerenome, Inc.

SEC filings and other documents